O&G SAQs · Antenatal care — fetal anomaly screening
Fetal structural anomalies — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on the mid-trimester anatomy scan: the systematic ISUOG protocol and cardiac views, interpretation of an isolated echogenic focus against prior screening, the hyperechogenic-bowel differential, and the microarray referral pathway for a structural anomaly. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
How this SAQ is marked
Twelve SAQs, 180 marks, two 2-hour papers — roughly 15 marks and 20 minutes each. Marks come from specifics: the ISUOG structures and cardiac views, the likelihood ratio and the prior-screening context, and the platform choice. Write in short labelled points. [1]
Reveal model answer and mark schemeShowHide
(a) Systematic anatomy scan and cardiac views (5 marks)
One mark per structure group and cardiac view, maximum five. [1][2]
- Systematic ISUOG order: head and brain, face, spine, heart, thorax, abdomen, limbs, plus biometry (BPD, HC, AC, FL) and growth.[1]
- Amniotic fluid, placenta, cord and cervix assessed at the same scan.[1]
- Cardiac views: four-chamber, left ventricular outflow tract, right ventricular outflow tract, and three-vessel-trachea.[2]
- A four-chamber view alone is insufficient — it misses transposition and obstructive lesions.[2]
(b) Echogenic intracardiac focus and its management (4 marks)
One mark per point, maximum four. [3][4]
- An echogenic intracardiac focus is a bright spot in the papillary muscle, usually a benign calcification; it is a soft marker for trisomy 21.[4]
- Positive likelihood ratio about 5.8 (Agathokleous 2013); most isolated markers have only a small effect on pre-test odds.[3]
- In this woman (low-risk cfDNA, isolated finding, otherwise normal scan), the appropriate management is reassurance and routine care — not amniocentesis.[4]
- Counsel that the marker is common and does not by itself indicate Down syndrome in a low-risk context.[3]
(c) Hyperechogenic bowel — differential and work-up (3 marks)
One mark per point, maximum three. [1]
- Differential is broader than aneuploidy: chromosome anomaly, cystic fibrosis, congenital infection (CMV), and bowel obstruction or meconium peritonitis.[1]
- Work-up: detailed fetal-medicine review, microarray, maternal CF carrier testing, and congenital-infection screen (CMV serology) as indicated.[1]
- Counselling is proportionate to the finding and the work-up results.[1]
(d) Major cardiac anomaly, normal karyotype — test, yield, pathway (3 marks)
One mark each for test, yield and pathway. [8]
- First-tier test: chromosomal microarray (not repeat karyotype).[8]
- Expected yield: clinically relevant copy-number variants in about 6.0% of structurally abnormal fetuses with a normal karyotype (Wapner 2012).[8]
- Pathway: fetal-medicine referral, detailed fetal echocardiography, and a multidisciplinary plan for place of delivery and neonatal cardiology; clinical genetics for any abnormal result.[2]
References5ShowHide
- [1]Salomon LJ, Alfirevic Z, Berghella V, et al. ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan Ultrasound Obstet Gynecol, 2022.PMID 35592929
- [2]International Society of Ultrasound in Obstetrics and Gynecology, Carvalho JS, Allan LD, et al. ISUOG Practice Guidelines (updated): sonographic screening examination of the fetal heart Ultrasound Obstet Gynecol, 2013.PMID 23460196
- [3]Agathokleous M, Chaveeva P, Poon LC, et al. Meta-analysis of second-trimester markers for trisomy 21 Ultrasound Obstet Gynecol, 2013.PMID 23208748
- [4]Lorente AMR, Moreno-Cid M, Rodríguez MJ, et al. Meta-analysis of validity of echogenic intracardiac foci for calculating the risk of Down syndrome in the second trimester of pregnancy Taiwan J Obstet Gynecol, 2017.PMID 28254219
- [8]Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis N Engl J Med, 2012.PMID 23215555